Jason is the Managing Director of Global Outcomes, LLC. With almost three decades of experience in pharmaceutical R&D, clinical research, and data science, Jason is often sought after for advice on innovative approaches to trial conduct and data management. He has been instrumental at helping move forward new techniques in using RWD in a clinical trial setting and helping build operational and commercial strategies to accelerate its adoption.
Prior to establishing Global Outcomes in 2022, Jason has held C-level and Executive level positions at many well-known companies in the pharmaceutical industry and clinical trial technology and services arena. He was most recently Chief Operating Officer at Signant Health, and prior to that served as Senior Vice President of Global Data Operations with Parexel International where he led a large global team in biostatistics, data management, statistical programming, and medical writing. In these roles he has led teams of several thousand people and been responsible for the execution of hundreds of simultaneous clinical studies across nearly all therapeutic areas and geographies active in clinical development.
In addition, Jason led the Customer Care, Development, Product, and Engineering teams at Medidata Solution for nearly 5 years during the company’s pivotal growth period. He is an expert in the application of EDC, CTMS, RTSM, eCOA and ePRO in clinical trials.
His transition into clinical research was preceded by over a decade in the R&D setting as head of Bioinformatics at Amgen Inc. and other biotech companies in the San Diego area. He also spent 6 years in the UK leading Amgen’s international R&D technology portfolio and serving with the international medical team during Amgen’s global expansion.
Jason has a BS with highest honors in Biochemistry from the University of California, Davis, an MS in Bioorganic Chemistry from University of California, Berkeley, and a dual executive MBA from London Business School and Columbia University in New York.
